GERN Q4 2024 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$48M+206582.6% YoY

Gross Profit

$47M98.4% margin

Operating Income

-$20M-42.2% margin

Net Income

-$25M-53.3% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+68.1%

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$44M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$594M

Total Liabilities

$313M

Stockholders' Equity

$280M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$23,000	+206582.6%
Gross Profit	$47M	$23,000	+203178.3%
Operating Income	-$20M	-$54M	+63.1%
Net Income	-$25M	-$52M	+51.2%

Revenue Segments

Revenues Before Adjustments

$57M54%

Product

$48M46%